Besides laboratory approaches and clinical studies correlating syncytin-1 expression in endometrial carcinoma, breast carcinoma and other tumours, we believe that syncytin should be studied in relation to histopathological and clinicopathological parameters in order to assess the relevance of this potential novel molecular target. The gene discussed is ERVW-1; the disease is breast carcinoma.